|
SearchRetinitis Pigmentosa: Free Medical and Health Information on RP Treatment and ResearchRetinitis Pigmentosa
Search within these results:
Identification of novel mutations in X-linked retinitis pigmentosa families and implications for dia
PURPOSE: The goal of this study was to identify mutations in X-chromosomal genes associated with retinitis pigmentosa (RP) in patients from Germany, The Netherlands, Denmark, and Switzerland.
Zurich, Switzerland Switzerland PURPOSE: To determine whether peripheral field loss (PFL) systematically distorts spatial representations and to determine whether persons with actual PFL show adaptation effects.
Baltimore, MD USA PURPOSE: To determine whether peripheral field loss (PFL) systematically distorts spatial representations and to determine whether persons with actual PFL show adaptation effects.
Baltimore, MD USA PURPOSE: The purpose of this project was to determine if mutations, including large insertions or deletions, in the recently identified RP31 gene topoisomerase I-binding arginine-serine rich (RS) protein (TOPORS), cause an appreciable fraction of autosomal dominant retinitis pigmentosa (adRP).
Houston, TX 77030 USA Evaluation of the common variants of the ABCA4 gene in families with Stargardt disease and autosomal
Stargardt disease (STGD) is one of the most common autosomal recessive retinal dystrophies with an estimated incidence of one in 10,000.
Rochester, MI 48309 USA Reported effects of non-traditional treatments and complementary and alternative medicine by retinit
BACKGROUND: Benefits of complementary and alternative medicine (CAM)-related interventions have been demonstrated for patients with chronic, systemic diseases in which stress, anxiety and disability are prevalent.
Baltimore, MD USA Purpose: The aim of this study was to assess the neuroprotective effect of a topical alpha(2)-agonist in patients with retinal dystrophies.
Jerusalem, Israel Israel Vision research involving stem cells is a rapidly evolving field.
Fullerton, CA USA |
PartnersLinksApproved By
|